Companies › Eligo Bioscience

Eligo Bioscience

Healthcare 📍 Paris, France 👥 11-50 employees 💰 $2.2M raised 📅 Founded 2014

Eligobiotics”, a new generation of antimicrobials that can be programmed to target bacteria based on their genome. Eligobiotics therefore provide a new approach to explore, understand and control bacterial ecosystems both in human and animals. They can notably be used to selectively eradicate harmful pathogens from the

📊 Company Overview

Sector
Healthcare
Country
France
Employees
11-50
Total Raised · Seed
$2.2M
Founded
2014
Cloud
AWS
CDN
Cloudflare
Email
Google Workspace

☁️ Cloud Infrastructure

AWS Detected Cloud Provider

Detected via HTTP headers

WorkspaceGoogle Workspace
CDNCloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year on AWS

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRMGoogle Analytics
CMS / PlatformWordPress
Frontend Stack🔒 Subscribers only

Detected from Eligo Bioscience's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction